These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18590012)

  • 1. [The National Board of Health and Welfare has the last word].
    Lindberg A; Möllergren M; Tegnell A
    Lakartidningen; 2008 May 28-Jun 3; 105(22):1685-7. PubMed ID: 18590012
    [No Abstract]   [Full Text] [Related]  

  • 2. New vaccines--new dilemmas.
    Passwell JH; Spirer Z
    Isr Med Assoc J; 2005 Jun; 7(6):397-9. PubMed ID: 15984386
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vaccination--value for money?].
    Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Kristiansen IS
    Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2670-3. PubMed ID: 17057767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Criteria for introducing new vaccines into the vaccination calendar].
    Ramírez Fernández R; Gutiérrez Rodríguez MA; Sanz Moreno JC
    Rev Esp Quimioter; 2007 Mar; 20(1):131-42. PubMed ID: 17530047
    [No Abstract]   [Full Text] [Related]  

  • 5. [National economic consequences of vaccines].
    Bergman A; Persson U
    Lakartidningen; 2008 May 28-Jun 3; 105(22):1680-4. PubMed ID: 18590011
    [No Abstract]   [Full Text] [Related]  

  • 6. Government financing for health and specific national budget lines: the case of vaccines and immunization.
    Lydon P; Beyai PL; Chaudhri I; Cakmak N; Satoulou A; Dumolard L
    Vaccine; 2008 Dec; 26(51):6727-34. PubMed ID: 18625279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Declaration of the National Institute of Public Health - National Institute of Hygiene on safety of vaccines and vaccinations].
    Wysocki MJ; Zieliński A; Brydak LB; Bucholc B;
    Przegl Epidemiol; 2010; 64(1):105-7. PubMed ID: 20499669
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicine. The intangible value of vaccination.
    Rappuoli R; Miller HI; Falkow S
    Science; 2002 Aug; 297(5583):937-9. PubMed ID: 12169712
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.
    Valentim J; Sartori AM; de Soárez PC; Amaku M; Azevedo RS; Novaes HM
    Vaccine; 2008 Nov; 26(49):6281-91. PubMed ID: 18674582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccination in a developmental perspective].
    Sommerfelt H; Godal T
    Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2674-7. PubMed ID: 17057768
    [No Abstract]   [Full Text] [Related]  

  • 11. Valuing vaccines: deficiencies and remedies.
    Bloom DE
    Vaccine; 2015 Jun; 33 Suppl 2():B29-33. PubMed ID: 26022563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flu vaccinations for school age children in England are cost effective, say experts.
    Iacobucci G
    BMJ; 2013 Jul; 347():f4749. PubMed ID: 23886968
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fear of adverse effects threatens the vaccination programs. Risk of re-emerging of "old-fashioned" childhood diseases with the reduced vaccination coverage].
    Olin P
    Lakartidningen; 2002 Apr; 99(16):1784-5. PubMed ID: 12043475
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt.
    Ortega O; El-Sayed N; Sanders JW; Abd-Rabou Z; Antil L; Bresee J; Mansour A; Adib I; Nahkla I; Riddle MS
    J Infect Dis; 2009 Nov; 200 Suppl 1():S92-8. PubMed ID: 19817621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.
    Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulating vaccines: can health-economics tools be used profitably?
    Dhanasiri SK; Puliyel JM
    Indian Pediatr; 2007 Jan; 44(1):11-4. PubMed ID: 17277425
    [No Abstract]   [Full Text] [Related]  

  • 17. [Who is to inform and who is to vaccinate? About new vaccines and vaccinations outside the general programs].
    Lindberg A; Tegnell A
    Lakartidningen; 2007 Feb 14-20; 104(7):490-2. PubMed ID: 17375678
    [No Abstract]   [Full Text] [Related]  

  • 18. [Priorities by the board of drug benefits--guidelines clarify. Clinical trials are not sufficient for decisions on subsidizing].
    Carlsson P
    Lakartidningen; 2003 Jul; 100(30-31):2428-9. PubMed ID: 12914137
    [No Abstract]   [Full Text] [Related]  

  • 19. [Health care politicians are not concerned about maximum health gain per crown].
    Nord E
    Tidsskr Nor Laegeforen; 1993 Apr; 113(11):1371-3. PubMed ID: 8337630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial barriers to implementing combination vaccines: perspectives from pediatricians and policy makers.
    Gidengil CA; Rusinak D; Allred NJ; Luff D; Lee GM; Lieu TA
    Clin Pediatr (Phila); 2009 Jun; 48(5):539-47. PubMed ID: 19318705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.